KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aehr Test Systems (AEHR) EBIT (2016 - 2026)

Aehr Test Systems' EBIT history spans 17 years, with the latest figure at -$4.2 million for Q1 2026.

  • For Q1 2026, EBIT fell 277.93% year-over-year to -$4.2 million; the TTM value through Feb 2026 reached -$16.1 million, down 23845.59%, while the annual FY2025 figure was -$5.7 million, 156.33% down from the prior year.
  • EBIT reached -$4.2 million in Q1 2026 per AEHR's latest filing, up from -$4.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $5.8 million in Q2 2022 to a low of -$4.6 million in Q4 2025.
  • Average EBIT over 5 years is $759352.9, with a median of $458000.0 recorded in 2022.
  • Peak YoY movement for EBIT: soared 868.39% in 2022, then tumbled 2657.23% in 2025.
  • A 5-year view of EBIT shows it stood at $3.5 million in 2022, then skyrocketed by 56.9% to $5.5 million in 2023, then tumbled by 127.67% to -$1.5 million in 2024, then crashed by 207.2% to -$4.6 million in 2025, then rose by 9.01% to -$4.2 million in 2026.
  • Per Business Quant, the three most recent readings for AEHR's EBIT are -$4.2 million (Q1 2026), -$4.6 million (Q4 2025), and -$4.1 million (Q3 2025).